Research

Repurposing RNA Sequencing for Discovery of RNA Modifications in Clinical Cohorts. (Sci Adv, Aug 2021)

Kar-Tong Tan 1 2 3, Ling-Wen Ding 4, Chan-Shuo Wu 1, Daniel G Tenen 5 6, Henry Yang 5 7 Affiliations 1Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. 2Biological and Biomedical Sciences Program, Division of Medical Sciences, Harvard Medical …

Repurposing RNA Sequencing for Discovery of RNA Modifications in Clinical Cohorts. (Sci Adv, Aug 2021) Read More »

Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation. (Genome Biol, Jun 2021)

Nisha Padmanabhan 1, Huang Kie Kyon # 1, Arnoud Boot # 2, Kevin Lim 1, Supriya Srivastava 3, Shuwen Chen 4, Zhiyuan Wu 5, Hyung-Ok Lee 6, Vineeth T Mukundan 7, Charlene Chan 7, Yarn Kit Chan 1, Ong Xuewen 1, Jason J Pitt 7, Zul Fazreen Adam Isa 1, Manjie Xing 1, Ming Hui Lee 1, Angie Lay Keng Tan 1, Shamaine Ho Wei Ting 1, Micah …

Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation. (Genome Biol, Jun 2021) Read More »

Mitochondria transfer from early stages of erythroblasts to their macrophage niche via tunnelling nanotubes. (Br J Haematol, Jun 2021)

Chong Yang 1, Mitsuhiro Endoh 1 2, Darren Q Tan 1, Ayako Nakamura-Ishizu 1 3, Yuji Takihara 1, Takayoshi Matsumura 1, Toshio Suda 1 4 Affiliations 1Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. 2Department of Pluripotent …

Mitochondria transfer from early stages of erythroblasts to their macrophage niche via tunnelling nanotubes. (Br J Haematol, Jun 2021) Read More »

SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic PTP4A3 through Chromatin Remodeling in t(4;14) Multiple Myeloma. (Cancer Res, May 2021)

Phyllis S Y Chong # 1, Jing Yuan Chooi # 2, Julia S L Lim 2 3, Sabrina Hui Min Toh 3, Tuan Zea Tan 3, Wee-Joo Chng 1 3 4 Affiliations 1Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. …

SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic PTP4A3 through Chromatin Remodeling in t(4;14) Multiple Myeloma. (Cancer Res, May 2021) Read More »

Monopar Announces New Drug Candidate, MNPR-202, and Enters into Collaboration Agreement with the National University of Singapore for Preclinical Evaluation in Cancer

Development of novel Camsirubicin analog expands Monopar’s therapeutic pipeline WILMETTE, Ill., June 03, 2021 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing …

Monopar Announces New Drug Candidate, MNPR-202, and Enters into Collaboration Agreement with the National University of Singapore for Preclinical Evaluation in Cancer Read More »

Extracellular Vesicles, the Cornerstone of Next-Generation Cancer Diagnosis? (Semin Cancer Biol, May 2021)

Jiayi Weng 1, Xiaoqiang Xiang 2, Lingwen Ding 3, Andrea Li-Ann Wong 4, Qi Zeng 5, Gautam Sethi 6, Lingzhi Wang 7, Soo Chin Lee 8, Boon Cher Goh 9 Affiliations 1Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore; Department of Medicine, Yong …

Extracellular Vesicles, the Cornerstone of Next-Generation Cancer Diagnosis? (Semin Cancer Biol, May 2021) Read More »

Targeting RNA Editing of Antizyme Inhibitor 1: a Potential Oligonucleotide-Based Antisense Therapy for Cancer (Mol Ther, May 2021)

Daryl Jin Tai Tay 1, Yangyang Song 1, Boya Peng 2, Tan Boon Toh 3, Lissa Hooi 1, Desiree-Faye Kaixin Toh 4, HuiQi Hong 5, Sze Jing Tang 1, Jian Han 1, Wei Liang Gan 1, Tim Hon Man Chan 1, Manchugondanahalli S Krishna 4, Kiran M Patil 4, Manikantha Maraswami 4, Teck Peng Loh 4, Yock Young Dan 6, Lei Zhou 7, Glenn …

Targeting RNA Editing of Antizyme Inhibitor 1: a Potential Oligonucleotide-Based Antisense Therapy for Cancer (Mol Ther, May 2021) Read More »